Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL: Safety Overview

Metric DOLUTEGRAVIR DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL
Total FAERS Reports 10,772 292
Deaths Reported 1,001 4
Death Rate 9.3% 1.4%
Hospitalizations 2,225 21
Average Patient Age 44.5 yrs 43.4 yrs
% Female Patients 42.1% 55.4%
FDA Approval Date Aug 12, 2013 N/A
Manufacturer ViiV Healthcare Company N/A
Route ORAL N/A
Marketing Status Prescription N/A